American Diabetes Association Pathway to Stop Diabetes 2015

To:	Chairs and Administrators; Departments in the Biological & Physical Sciences; Associate Deans for Research; School/College Research Administrators
From:	Office of the Vice Chancellor for Research & Graduate Education
Date:	March 19, 2015
Subject:	American Diabetes Association Pathway to Stop Diabetes 2015

Deadline

Deadline for Internal Review:

May 08, 2015

Project Description

The American Diabetes Association (ADA) Pathway Awards program supports innovative basic, clinical, translational, epidemiological, behavioral, or health services research relevant to any diabetes type, diabetes-related disease state, or diabetes complication. The Association seeks exceptional candidates from a broad range of disciplines, including medicine, biology, chemistry, computing, physics, mathematics and engineering.

Initiator Award (INI) is a two-phased award designed to support the transition from mentored training to independent research faculty. Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. Awards provide two distinct phases of research support: Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs). Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Combined support for Phase 1 and Phase 2 can total up to $1,625,000.

Accelerator Award (ACE) is designed to support exceptional early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, independent diabetes research programs. Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for, or received, an R01/U01 renewal or a second R01/U01 award. Awards provide five years of research support at a maximum of $325,000 per year (including 30% indirect costs), for a total of $1,625,000.

Visionary Award (VSN) is designed to support established, experienced investigators with strong records of outstanding productivity in fields outside of diabetes who are interested in applying their considerable skills and expertise to diabetes research. These awards are highly competitive and intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes.

Applicants must hold independent faculty positions and have demonstrated significant productivity in their current field of research. Applicants cannot have previously received national grant support (NIH, NIDDK, ADA, JDRF, etc.), as either a PI or Co-PI, in diabetes or diabetes-related research. Awards provide two distinct phases of research support: Phase 1 provides up to three years of support at a maximum of $325,000 per year (including 30% indirect costs), Phase 2 provides up to two years of support at a maximum of $325,000 per year (including 30% indirect costs). Phase 2 is contingent upon demonstration of significant contributions to the field of diabetes research in Phase 1. Combined support for Phase 1 and Phase 2 can total up to $1,625,000.

Eligibility

The number of proposals UW–Madison may submit is limited to one in total.

Website

The following link contains additional information on the program and specific application instructions:
http://www.diabetes.org/pathway/

Internal Competition Application Instructions

Sponsor Deadlines

Applications are due to the sponsor by July 01, 2015.

Questions?

Contact grants@research.wisc.edu.